Limas



Indications and Reactions:

Role Indications Reactions
Secondary
Bipolar I Disorder 17.4%
Schizophrenia, Paranoid Type 16.7%
Bipolar Disorder 10.1%
Drug Use For Unknown Indication 6.6%
Product Used For Unknown Indication 6.6%
Constipation 5.9%
Depression 5.9%
Mania 5.6%
Schizophrenia 5.6%
Parkinson's Disease 4.2%
Interstitial Lung Disease 3.5%
Insomnia 2.4%
Affective Disorder 2.1%
Major Depression 2.1%
Hypertension 1.7%
Partial Seizures 1.0%
Anxiety 0.7%
Benign Prostatic Hyperplasia 0.7%
Delusional Disorder, Unspecified Type 0.7%
Depressive Symptom 0.7%
Therapeutic Agent Toxicity 12.7%
Somnolence 10.9%
Liver Disorder 7.3%
Stevens-johnson Syndrome 7.3%
Tremor 7.3%
White Blood Cell Count Increased 7.3%
Renal Impairment 5.5%
Somnolence Neonatal 5.5%
Vomiting 5.5%
Delirium 3.6%
Malaise 3.6%
Neuroleptic Malignant Syndrome 3.6%
Rash 3.6%
Sick Sinus Syndrome 3.6%
Water Intoxication 3.6%
Anaphylactic Reaction 1.8%
Aspartate Aminotransferase Increased 1.8%
Autoimmune Thyroiditis 1.8%
Blood Creatine Phosphokinase Increased 1.8%
Decreased Appetite 1.8%
Concomitant
Bipolar Disorder 16.2%
Bipolar I Disorder 15.2%
Depression 12.5%
Insomnia 8.1%
Schizophrenia 6.7%
Schizophrenia, Paranoid Type 5.1%
Product Used For Unknown Indication 4.6%
Sleep Disorder 4.0%
Schizophrenia, Disorganised Type 3.9%
Constipation 3.6%
Substance-induced Psychotic Disorder 3.5%
Asthma 2.7%
Prophylaxis 2.6%
Schizophrenia, Undifferentiated Type 2.2%
Hypertension 1.7%
Anxiety 1.6%
Bipolar Ii Disorder 1.6%
Drug Use For Unknown Indication 1.5%
Schizoaffective Disorder 1.3%
Hyperlipidaemia 1.3%
White Blood Cell Count Increased 13.5%
Vomiting 10.7%
Rhabdomyolysis 9.6%
Rash 8.4%
White Blood Cell Count Decreased 6.7%
Tremor 5.6%
Stevens-johnson Syndrome 4.5%
Mania 3.9%
Pyrexia 3.9%
Sudden Death 3.9%
Completed Suicide 3.4%
Salivary Hypersecretion 3.4%
Serotonin Syndrome 3.4%
Hepatic Function Abnormal 2.8%
Interstitial Lung Disease 2.8%
Neuroleptic Malignant Syndrome 2.8%
Rash Generalised 2.8%
Skin Disorder 2.8%
Suicidal Ideation 2.8%
Granulocyte Count Decreased 2.2%
Interacting
Depressed Mood 33.3%
Depressive Symptom 33.3%
Gonarthrosis 33.3%
Somatoform Disorder Neurologic 50.0%
Somnolence 50.0%